SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001169232-09-000992
Filing Date
2009-02-17
Accepted
2009-02-17 14:59:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO NO. 2 SCHEDULE 13G d76200_sc13g-a.txt SC 13G/A 10023
  Complete submission text file 0001169232-09-000992.txt   12031
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Subject) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79884 | Film No.: 09611141
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 WILSHIRE BOULEVARD SUITE 960 SANTA MONICA CA 90401
Business Address 100 WILSHIRE BOULEVARD SUITE 960 SANTA MONICA CA 90401 310-899-0800
Aletheia Research & Management, Inc. (Filed by) CIK: 0001302506 (see all company filings)

IRS No.: 954647814 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A